THC Therapeutics Engage Milestone Management Services for Investor Relations - Seite 2
About THC Therapeutics, Inc. (THCT):
THC Therapeutics, Inc., is focused on developing its patented dHydronator, a sanitizing herb dryer. The main function of the dHydronator is to greatly accelerate the drying time of an herb while
sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with Cannabis. It will reduce the drying time for cannabis from 10-14 days down to
less than 14 hours while dramatically reducing viability of microbial contaminants. The Company may focus some of its future operations on participation in Cannabis-testing lab facilities,
Cannabis-infused beverages, and the edible markets. THCT is seeking partnerships with companies in the cannabis, wellness, and Technologies industries in the United States & Canada.
Forward Looking Statements:
This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.
Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with execution of the company’s business plan, development and production of our products, supply and distribution issues, and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.